فهرست و منابع تحقیق مقاله نو پدیدی ویروس هرپس انسانی تایپ 8
فهرست:
ندارد.
منبع:
منابع
1) Dukers, Nicole HTM a. Rezza, Giovanni b. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS. 17(12): 1717-1730, August 15, 2003.
2) Casper, C, Wald, A, Pauk, J, et al. Correlates of Prevalent and Incident Kaposi’s Sarcoma-Associated Herpesvirus Infection in Men Who Have Sex with Men. J Infect Dis 2002; 185: 990.
3) Jenson, Hal B. MD. Human herpesvirus 8 infection. Current Opinion in Pediatrics. 15 (1): 85-91, February 2003.
4) Okano, Hiroshi. Shiraki, Katsuya. Inoue, Hidekazu. Kawakita, Tomoyuki. Yamanaka, Takenari. Deguchi, Masatoshi. Sugimoto, Kazushi. Sakai, Takahisa. Ohmori, Shigeru. Fujikawa, Katsuhiko. Murata, Kazumoto. Nakano, Takeshi. Cellular FLICE/Caspase-8-Inhibitory Protein as a Principal Regulator of Cell Death and Survival in Human Hepatocellular Carcinoma. Laboratory Investigation. 83(7): 1033-1043, July 2003.
5) Nasti, Guglielmo. Talamini, Renato. Antonori, Andrea. Martellotta, Ferdinando. Jacchetti, Gaia. Chiodo, Francesco. Ballardini, Giuseppe. Stoppini, Laura. Di Perri, Giovanni. Mena, Maurizio. Tavio, Marcello. Vaccher, Emanuela. Monforte, Antonella D Arminio. Tirelli, Umberto. AIDS-Related Kaposi’s Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging System in the Haart Era-the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. Journal of Clinical Oncology. 21(15): 2876-2882, August 1, 2003.
6) Flore, O, Rafii, S, Ely, S, et al. Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus. Nature 1998; 394: 588.
7) Engels, Eric A. Biggar, Robert J. Marshall, Vickie A a. Walters, Michael AKL a. Gamache, Christine J a. Whitby, Denise a. Goedert, James J. Detection and quantification of Kaposi’s sarcoma-associated herpesvirus to predict AIDS-associated Kaposi’s sarcoma. AIDS. 17(12): 1847-1851, August 15, 2003.
8) Andreoni, M, Sarmati, L, Nicastri, E, et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002; 287: 1295.
9) Tang, J 1. Gordon, G M 1. Mueller, M G 1. Dahiya, M 2. Foreman, K E 1. The Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of Id-1, a critical cell cycle regulatory protein, in human endothelial cells. Journal of Investigative Dermatology. 121(1), July 2003.
10) Uccini, Stefania MD. Scarpino, Stefania PhD. Ballarini, Francesca PhD. Soriani, Alessandra PhD. Chilosi, Marco MD. Montesu, Maria Antonietta MD. Masala, Maria Vittoria MD. Cottoni, Francesca MD. Ruco, Luigi MD. In Situ Study of Chemokine and Chemokine-Receptor Expression in Kaposi Sarcoma. American Journal of Dermatopathology. 25(5): 377-383, October 2003.
11) West, John T 1. Wood Charles *, 1. The role of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Orgaene. 22(33): 5150-5163, August 11, 2003.
12) An, Jiabin 1. Sun, Yiping 1. Sun, Ren 2. Rettig, Matthew B 1,3. Kaposi’s sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-[kappa]B and JNK/AP1 pathways. Oncogene. 22 (22): 3371-3385. May 29, 2003.
13) Cannon, Michael J a, b. Dollard, Sheila C b. Black. Jodi B b,c. Edlin, Brian R b, d. Hannah Connie e. Hogan, Susan E a. Patel, Mitesh M b. Jaffe, Harold W b. Offermann, Margaret K a. Spira, Thomas J b. Pellett, Philip E b. Gunthel, Clifford J a. Risk factors for Kaposi’s sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS. 17 (2): 215-222, January 24, 2003.
15) Cesarman, Ethel.. Kaposi’s Sarcoma-Associated Herpesvirus-The High Cost of Viral Survival. New England Journal of Medicine. 349 (12): 1107-1109, September 18, 2003.
16) OZA, UMESH D.M.D. 1. MUNN, SAMSON M.D. 2. Imaging HIV/AIDS: Body Cavity-Based Lymphoma. AIDS Patient Care & Stds. 17(3): 129-132, March 2003.
17) Oksenhendler, E, Boulanger, E, Galicier, L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Catleman disease. Blood 2002; 99: 2331.
18) Hsu, HC, Lee, YM Yang, CF, et al. Detection of Kaposi sarcoma-associatred herpesvirus un bone marrow biopsy samples from patients with multiple myeloma. Cancer 2001; 91: 1409.
19) Lasota, J, Miettinen, M. Absence of Kaposi’s sarcoma-associated virus (human herpesvirus-8) sequences in angiosarcoma. Virchows Arch 1999; 434:51.
20) Maeda, H, Niimi, T, Sato, S, et al. Human herpesvirus 8 is not associated with sarcoidosis in Japanese patients. Chest 2000; 118: 923.
21) Cool, Carlyne D.. Rai, Pradeep R.. Yeager, Michael E.. Hernandez-Saavedra, Daniel. Serls, Ammanda E.. Bull, Todd M.. Geraci, Mark W.. Brown, Kevin K.. Routes, John M.. Tuder, Rubin M.. Voelkel, Norbert F.. Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension. New England Journal of Medicine. 349 (12): 1113-1122, September 18, 2003.
22) Cattani, P. 1. Cerimele, F. 1. Porta, D. 2. Graffeo, R. 1. Ranno, S. 1. Marchetti, S. 1. Ricci, R. Capodicasa, N. 3. Fuga, L. 3. Amico, R. 3. Cherchi, G. 4. Gazzilli, M. 4. Zanetti, S. 5. Fadda, G. 1. Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regions. Clinical Microbiology & Infection. 9(4): 274-279, April 2003.
23) Baluvelt, A, Sei, S, Cook, PM, et al. Human herpesvirus 8 infection occurs following adolescence in the United States. J Infect Dis 1997; 176: 771.
24) Martin, JN, Ganem, DE, Osmond, DH, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N. Engl J Med 1998; 338: 948.
25) Melbye, M, Cook, OM, Hjalgrim, H, et al. Risk factors for Kaposi’s-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77: 543.
26) Simpson, GR, Schulz, TF, Whitby, D, et al. Prevalence of Kaposi’s sarcoma associated herpesvirus infection measuredby antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133.
27) Lppi, Mario. Barozzi, Patrizia. Torelli, Giuseppe. Skin Cancers after Organ Transplantation. New England Journal of Medicine. 349(6): 612-614, August 7, 2003.
28) Lennette, ET, Blackbourn, DJ, Levy, JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet 1996; 348:858.
29) Enbom, M, Sheldon, J, Lennette, E, et al. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J med Virol 2000; 62:498.
30) Boivin, G, Gaudreau, A, Toma, E, et al. Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi’s sarcoma and response to anticytomegalovirus therapy. Antimicrob Agents Chemother 1999; 43:377.
31) Leao, JC, Kumar, N, McLean, KA, et al. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients. J Med Virol 2000; 62:416.
32) Rey, D, Schmitt, MP, Partisani, M, et al. Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks. J Acquir Immune Defic Syndr 2001; 27:459.
33) Monini, Paolo. Sgadari, Ceciolia. Barillari, Giovanni. Ensoli, Barbara*. HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity. Journal of Antimicrobial Chemotherapy. 51(2):207-211, February 2003.
34) Portsmouth, Simon. Stebbing, Justin. Gill, Jas. Mandalia, Sundhiya. Bower, Mark. Nelson, Mark. Bower, Mark. Gazzard, Brian. A comparison of regimens of regimens based on non-nucleoside reverse transcriptase inhibitors oir protease inhibitors in preventing Kaposi’s sarcoma. AIDS. 17(11):F17-F22, July 25, 2003.
35) Marrache, Frederic a. Larroche, Claire a. Memain, Nathalie a. Bouchaud, Olivier a. Robineau, Michel a. Hermine, Olivier b. Lortholary, Olivier a. Prologed remission of HIV-associated multicentric Castelman’s disease with an anti-CD20 monoclonal antibody as primary therapy. AIDS. 17(9):1409-1410, Hune 13, 2003.
36) Stebbing, Justin MA MRCP 1. Portsmouth, Simon BSc MRCP 2. Gotch, Frances PhD 1. Gazzard, Brian FRCP 2. Kaposi’s sarcoma – an update. International Journal of STD & AIDS. 14 (4):225-227, April 2003.
37) Nord, J A MD. Karter, D MD. Low dose interferon-[alpha] therapy for HIV-associated multicentric Castleman’s disease. International Journal of STD & AIDS. 14(1):61-62, January 2003.
38) Requena, Luis MD. Kutzner, Heinz MD. Palmedo, Gabriele PhD. Calonje, Eduardo MD. Requena, Celia MD. Perez, Gemma MD. Pastor, Maria Antonia MD. Sangueza, Omar P. MD. Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases. Archives of Dermatology. 139(4):475-486, April 2003.